FATE
FATE THERAPEUTICS INC
NASDAQ · Healthcare · Biotechnology · US
$2.53
+0.40%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 71.15x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.98x
- Price / sales
- 46.70x
- Price / cash flow
- -2.97x
Enterprise value
- Enterprise value
- $225.1M
- EV / sales
- 34.67x
- EV / EBITDA
- -1.92x
- EV / EBIT
- -1.68x
- Market cap
- $303.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026